Top market and economy voices on steel prices, semiconductor shortage, Wipro, and more

SUMMARY

Here is what market gurus and industry captains said about the near-term trajectory on April 16, 2021.

By CNBCTV18.comApr 16, 2021 5:27:09 PM IST (Published)

On Motherson Sumi | Vivek Chaand Sehgal, Chairman of Motherson Sumi: The demand is very positive, there are no red flags that we have come across. There is an upward demand people are going up so the luxury cars are also doing very well, the personal mobility has picked up, so really nothing to worry about in any way. Catch the conversationhere.

On Steel prices | VR Sharma, MD of JSPL: The market has been excellent in the last few months, there has been good demand. This is a pent-up demand coupled with true and real demand worldwide. I think this is going to continue at least for another one year time. The demand is also picking up every day. So I feel the price increase in the last three months that we have seen, this particular rally will keep on. Catch the conversationhere.

On semiconductor shortage | Vinod Dasari the CEO of Royal Enfield: This year, fortunately, we have a very good demand, we have a huge backlog and yes there are these sporadic problems here and there. We have to maintain all safety protocols and SOPs that have been laid out. The industry now knows how to operate in this kind of environment. Supply chain constraints will come and go that is short-term, I think in the long run the automotive industry has learnt to deal with things in a newer way. Catch the conversationhere.

On Wipro | Prakash Diwan, Market Expert: I would believe there would be a rerating on Wipro. There is another 10-15 percent of an upside for sure. It is after that 25-26 times P/E multiples is when it would probably see a little bit of consolidation.

On Pharma | Dipan Mehta of Elixir Equities: Pharmaceutical space is a safe place to hide at this point in time. We and our clients may be invested in two stocks that will clearly benefit from the COVID-19 situation, Dr Reddy’s Laboratories (DRL) and Cipla. Given the valuations, I am very positive about both Cipla and DRL. Both these companies can deliver exceptional returns over the next two three years or so.